EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota-Derived Metabolites in Atherosclerosis: Pathways, Biomarkers, and Targets

Alexandra-Kristine Tonch-Cerbu iD, Adrian-Gheorghe Boicean iD, Oana-Maria Stoia iD, Minodora Teodoru iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178488 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alexandra-Kristine Tonch-Cerbu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinical Department, Faculty of Medicine, "Lucian Blaga" University, 550024 Sibiu, Romania. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Atherosclerosis, Biomarkers. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human gut microbiota is a complex ecosystem that influences host metabolism, immune function, and cardiovascular health. Dysbiosis, defined as an imbalance in microbial composition or function, has been linked to the development and progression of atherosclerosis. This connection is mediated by microbial metabolites that enter the systemic circulation and interact with vascular and immune pathways. Among these, trimethylamine N-oxide (TMAO) has been most extensively studied and is consistently associated with cardiovascular events. Other metabolites, including lipopolysaccharides (LPS), short-chain fatty acids (SCFAs), and secondary bile acids, also contribute by modulating inflammation, endothelial function, and lipid metabolism. Recent research has expanded to emerging metabolites such as indoxyl sulfate, indole-3-propionic acid, and polyamines, which may provide additional mechanistic insights. These microbial products are increasingly explored as biomarkers of cardiovascular risk. TMAO has shown predictive value in large human cohorts, while microbiota composition and diversity measures remain less consistent across studies. However, interpretation of these biomarkers is limited by methodological variability, interindividual differences, and lack of standardization. Therapeutic interventions targeting the gut–heart axis are under investigation. Dietary strategies such as the Mediterranean diet and fiber-rich nutrition, probiotics and prebiotics, and fecal microbiota transplantation (FMT) show promise, while pharmacological approaches targeting TMAO or bile acid pathways are in early stages. This review summarizes current knowledge on the mechanistic, diagnostic, and therapeutic links between the gut microbiota and atherosclerosis, highlighting both established findings and emerging directions for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeAtherosclerosisBiomarkersHumansMethylaminesAnimalsDysbiosisBile Acids and Salts

Stichwörter der Autor:innen

atherosclerosisbiomarkersdysbiosisgut microbiotametabolitesprebioticsprobioticstherapeutic strategies

Substanzen

BiomarkersMethylaminestrimethyloxamineBile Acids and Salts

Autor:innen und Institutionen

  • Medical Clinical Department, Faculty of Medicine, "Lucian Blaga" University, 550024 Sibiu, Romania.
  • County Clinical Emergency Hospital of Sibiu, 550245 Sibiu, Romania.

ORCID-Profile: Alexandra-Kristine Tonch-Cerbu, Adrian-Gheorghe Boicean, Oana-Maria Stoia, Minodora Teodoru

Zitieren

APA

Tonch-Cerbu, A. K., Boicean, A. G., Stoia, O. M., & Teodoru, M. (2025). Gut Microbiota-Derived Metabolites in Atherosclerosis: Pathways, Biomarkers, and Targets. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178488

Vancouver

Tonch-Cerbu AK, Boicean AG, Stoia OM, Teodoru M. Gut Microbiota-Derived Metabolites in Atherosclerosis: Pathways, Biomarkers, and Targets. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178488

BibTeX
@article{TonchCerbu2025,
  author = {Tonch-Cerbu, Alexandra-Kristine and Boicean, Adrian-Gheorghe and Stoia, Oana-Maria and Teodoru, Minodora},
  title = {Gut Microbiota-Derived Metabolites in Atherosclerosis: Pathways, Biomarkers, and Targets},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178488}
}
Kostenlos starten →